G12.21
Amyotrophic lateral sclerosis
Clinical Classification Guidelines
Medical Intelligence & Overview
Amyotrophic lateral sclerosis, commonly known as ALS, is a progressive neurological disease that affects nerve cells in the brain and spinal cord. This condition leads to the gradual loss of muscle control, impacting a person’s ability to move, speak, eat, and breathe. ALS is also referred to as Lou Gehrig’s disease, named after the famous baseball player who was diagnosed with it. The progression of ALS varies among individuals, but it generally worsens over time, leading to significant disability. Although there is currently no cure for ALS, supportive treatments and therapies can help manage symptoms and improve quality of life.
Causes & Symptoms
Clinical Causes: Most cases of ALS are sporadic, meaning they occur without a clear family history, and the exact cause remains unknown. Genetic factors play a role in about 5-10% of cases, with specific gene mutations linked to familial ALS. Environmental exposures, such as prolonged exposure to toxins, heavy metals, and pesticides, may contribute to risk in some individuals. Other factors like smoking and intense physical activity have been studied but lack definitive evidence. Research is ongoing to better understand the complex interplay of genetic and environmental influences in ALS development.
Key Symptoms: Muscle weakness, often beginning in the arms or legs Muscle cramps and twitching ( fasciculations) Difficulty speaking or swallowing Loss of coordination and muscle stiffness Progressive paralysis affecting mobility Difficulty breathing as respiratory muscles weaken Unintended weight loss in advanced stages Cognitive changes or behavioral changes in some cases
Diagnostic & Treatment
Diagnosis Path: A detailed neurological examination assessing muscle strength, reflexes, and coordination Electromyography (EMG) to evaluate electrical activity in muscles Nerve conduction studies to measure nerve function Imaging tests like MRI to rule out other conditions Blood and urine tests to exclude alternative causes Referral to specialists and continuous monitoring for symptom progression
Treatment Protocols: Medications such as riluzole and edaravone may help slow disease progression Physical therapy to maintain mobility and function Occupational therapy to assist with daily activities Speech therapy to improve communication and swallowing Breathing support, including ventilators, as respiratory muscles weaken Nutritional support with special diets or feeding tubes if swallowing becomes difficult Psychological support for patients and families to cope with emotional and mental health challenges
Clinical Advice & FAQs
Billing Guidance
Is G12.21 a billable ICD-10 code?
Yes, G12.21 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report G12.21?
Clinical documentation must specify the nature of Amyotrophic lateral sclerosis and any associated comorbidities for accurate reporting.
Cite this Clinical Reference